BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 06/12/2024

FDA Announces Draft Guidance for Expedited Program for Serious Conditions-Accelerated Approval of Drugs and Biologics

The FDA is releasing a draft guidance for industry on its Expedited Program for Serious Conditions, which aims to speed up the development and review of life-threatening drugs and biologics.

Source: Federal Register — Food and Drug AdministrationOpen original release →